Published: 2022-08-29

The prevalence of atopic dermatitis among children aged between 6 months and 12 years attending primary health care clinics in Qatar 2018-2019

Boby John Oommen, Waad Ibrahim Majeed Kadori, Jazeel Abdulmajeed, Jeyaram Illiayaraja Krishnan, Shajitha Thekke Veettil


Background: The prevalence of atopic dermatitis among children appears to have increased dramatically over the past decades. Such rapid increase in prevalence cannot be explained fully. Genetic factors, microbiomes (especially staphylococcus aureus infection), food allergy and environmental factors might play a role in such an increment. This study aimed to report the prevalence of atopic dermatitis among children aged 6 months to 12 years attending primary health care centers in Qatar during the year 2018 and 2019.

Methods: Cross-sectional retrospective data analysis of all registered cases having at least one visit in any of the 28 health centers dermatology clinics operated by PHCC with a verified diagnosis of atopic dermatitis

Results: Out of 4521 patients dermatology clinic visit, 1359 had atopic dermatitis during the period of 2018 and 2019, and the prevalence rate is 30.06 (95% CI 28.72-31.42). In this 1359 atopic dermatitis cases, mean age of patients was 5.09±3.53 years and ranged from 6 months to 12 years. In this 18.9% was <1 years, 41.43% was 1-5 years, 19.35% was 5-8 years and 21.04% was 8-12 years. Prevalence of AD is high in boys 31.42% than girls 28.81% and is high in Qatari population 34.4% than the non-Qatari population 28.7%. The most frequently prescribed medication group was topical emollients (89.8%) followed by antihistamine (81.24%) and antibiotics (56.73%). Steroids were prescribed only for 7.3% of cases.

Conclusions: In this study the prevalence of atopic dermatitis was remarkably very high in young children in Qatar. Further prospective research and more efforts are needed to develop a standard treatment regimen for allergic diseases in Qatar.


Prevalence, atopic dermatitis, children, primary care, Qatar

Full Text:



Nice. Atopic eczema in under 12s: diagnosis and management, 2021. Available at: guidance/cg57. Accessed on 20 October 2021.

NHS. Atopic eczema, 2021. Available at: conditions/atopic-eczema. Accessed on 20 October 2021.

Medline plus. Atopic dermatitis, 2021. Available at: https://medlineplus. gov/genetics/condition/atopic-dermatitis/#genes. Accessed on 20 October 2021.

Williams H, Burney PG, Hay RJ, Archer CB, Shipley MJ, Hunter JJ, et al. The UK working party’s diagnostic criteria for atopic dermatitis. Br J Dermatol. 1994;131(3):383-96.

SIGN. Management of atopic eczema in primary care, 2021. Available at: Accessed on 20 October 2021.

Atopic dermatitis (eczema): pathogenesis, clinical manifestations, and diagnosis. Available at: Accessed on 20 October 2021.

Diana P. Guidelines for the diagnosis and assessment of eczema. Available at: guidelines-for-the-diagnosis-and-assessment-of-eczema. Accessed on 20 October 2021.

Al-Herz W. A systematic review of the prevalence of atopic diseases in children on the Arabian Peninsula. Med Princ Pract. 2018;27(5):436-42.

Soyoung H, Son DK, Lim WR, Kim SH, Kim H, Yum HY, et al. The prevalence of atopic dermatitis, asthma, and allergic rhinitis and the comorbidity of allergic diseases in children. Environ Health Toxicol. 2012;27:e2012006.

Asher MI. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006;368:733-43.

Silverberg JI, Barbarot S, Gadkari A, Simpson EL, Weidinger S, Mina-Osorio P, et al. Atopic dermatitis in the pediatric population: A cross-sectional, international epidemiologic study. Ann Allergy Asthma Immunol. 2021;126(4):417-28.

Hammoudeh S, Hani Y, Alfaki M, Omar N, El Dimassi D, Nowir K, et al. The prevalence of asthma, allergic rhinitis, and eczema among school-aged children in Qatar: a global asthma network study. Pediatr Pulmonol. 2022.

Harthi SA, Wagdani AA, Sabbagh A, Ghamdi AA, Duruk IA. Prevalence of asthma among saudi children in Makkah, Saudi Arabia. Int J Adv Res. 2017;5: 1209-14.

Dalibalta S, Samara F, Qadri H, Adouchana H. Potential causes of asthma in the United Arab Emirates: drawing insights from the Arabian Gulf. Rev Environ Health. 2018;33(2):205-12.

Behbehani NA, Abal A, Syabbalo NC, Abd Azeem A, Shareef E, Al-Momen J. Prevalence of asthma, allergic rhinitis, and eczema in 13 to 14 year-old children in Kuwait: an ISAAC study. International Study of Asthma and Allergies in Childhood. Ann Allergy Asthma Immunol. 2000;85(1):58-63.

Kim HY, Kwon EB, Baek JH. Prevalence and comorbidity of allergic diseases in preschool children. Korean J Pediatr. 2013;56(8):338-42.

Del-Río-Navarro BE, Berber A, Reyes-Noriega N. Global asthma network phase i study in mexico: prevalence of asthma symptoms, risk factors and altitude associations-a cross-sectional study. BMJ Open Respir Res. 2020;7(1):e000658.

Zar HJ, Ehrlich RI, Workman L, Weinberg EG. The changing prevalence of asthma, allergic rhinitis and atopic eczema in African adolescents from 1995 to 2002. Pediatr Allergy Immunol. 2007;18(7):560-5.

Vichyanond P, Jirapongsananuruk O, Visitsuntorn N, Tuchinda M. Prevalence of asthma, rhinitis and eczema in children from the Bangkok area using the ISAAC (International Study for Asthma and Allergy in Children) questionnaires. J Med Assoc Thai. 1998; 81(3):175-84.

Pearce N, Aït-Khaled N, Beasley R, et al. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax. 2007;62(9):758-66.

Alahmadi TS, Banjari MA, Alharbi AS. The prevalence of childhood asthma in Saudi Arabia. Int J Pediatr Adolesc Med. 2019;6(2):74-7.

Al-Riyami BMS, Al-Rawas OAS, Al-Riyami AA, Jasim LG, Mohammed AJ. A relatively high prevalence and severity of asthma, allergic rhinitis and atopic eczema in schoolchildren in the Sultanate of Oman. Respirol. 2003;8(1):69-76.

Al-Riyami BMS, Al-Rawas OAS, Al-Riyami AA, Jasim LG, Mohammed AJ. Prevalence of asthma symptoms in Omani schoolchildren. J Sci Res Med Sci. 2001;3:21-7.

Al-Sindi H, Mulla M, Bu-Saibaa A, Sharaf B, Jawad JS, Karim OA. Prevalence of asthma and allergic diseases in children aged 6-7 in the Kingdom of Bahrain. J Bahrain Med Soc. 2014;25:71-4.

Al-Afif K, Buraik MA, Buddenkotte J, Mounir M, Gerber R, Ahmed HM, et al. Understanding the burden of atopic dermatitis in Africa and the Middle East. Dermatol Ther. 2016;9(2):223-41.

Farajzadeh S, Esfandiarpour I, Sedaghatmanesh M, Saviz M. Epidemiology and clinical features of atopic dermatitis in Kerman, a desert area of Iran. Ann Dermatol. 2014;26:26-34.

Yousuf MS. Managing childhood eczema in the Middle East. Wound Int. 2010;1:20-2.

Obeng BB, Hartgers F, Boakye D, Yazdanbakhsh M. Out of Africa: what can be learned from the studies of allergic disorders in Africa and Africans?. Curr Opin Allergy Clin Immunol. 2008;8:391-7.

Guo Y. Prevalence of atopic dermatitis in chinese children aged 1-7 years. Sci Rep. 2016;6;29751.

Hanifin JM, Cooper KD, Ho VC, Kang S, Krafchik BR, Margolis DJ, et al. Guidelines of care for atopic dermatitis, developed in accordance with the American academy of dermatology (AAD)/American academy of dermatology association “administrative regulations for evidence-based clinical practice guidelines. J Am Acad Dermatol. 2004;50:391-404.

Eichenfield LF, Tom WL, Berger TG, Harrod CG, Begolka WS, Sidbury R, et al. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116-32.